Mitsubishi UFJ Trust & Banking Corp Boosts Position in Cigna Corp. (CI)

Mitsubishi UFJ Trust & Banking Corp boosted its stake in shares of Cigna Corp. (NYSE:CI) by 1.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 558,994 shares of the company’s stock after buying an additional 6,937 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned approximately 0.22% of Cigna Corp. worth $72,848,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in CI. Cohen & Steers Inc. increased its stake in shares of Cigna Corp. by 5,076.6% in the second quarter. Cohen & Steers Inc. now owns 4,557,918 shares of the company’s stock valued at $403,011,000 after buying an additional 4,469,870 shares in the last quarter. Nordea Investment Management AB boosted its stake in Cigna Corp. by 184.4% in the third quarter. Nordea Investment Management AB now owns 3,292,089 shares of the company’s stock worth $429,025,000 after buying an additional 2,134,355 shares during the period. Dodge & Cox boosted its stake in Cigna Corp. by 12.8% in the second quarter. Dodge & Cox now owns 15,282,616 shares of the company’s stock worth $1,956,022,000 after buying an additional 1,728,391 shares during the period. Emerald Acquisition Ltd. acquired a new stake in Cigna Corp. during the second quarter worth approximately $162,107,000. Finally, Alliancebernstein L.P. boosted its stake in Cigna Corp. by 90.9% in the second quarter. Alliancebernstein L.P. now owns 2,177,144 shares of the company’s stock worth $278,653,000 after buying an additional 1,036,848 shares during the period. 84.54% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Cigna Corp. (NYSE:CI)

Shares of Cigna Corp. (NYSE:CI) opened at 138.61 on Tuesday. Cigna Corp. has a 52-week low of $115.03 and a 52-week high of $148.99. The stock has a market cap of $35.59 billion, a price-to-earnings ratio of 18.84 and a beta of 0.54. The stock’s 50 day moving average is $135.53 and its 200 day moving average is $130.18.

Cigna Corp. (NYSE:CI) last issued its earnings results on Thursday, November 3rd. The company reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.03. Cigna Corp. had a net margin of 4.87% and a return on equity of 16.17%. The company had revenue of $9.90 billion for the quarter, compared to analyst estimates of $4.37 billion. During the same period in the prior year, the business posted $2.28 earnings per share. The firm’s revenue for the quarter was up 5.2% compared to the same quarter last year. On average, equities analysts expect that Cigna Corp. will post $7.98 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece on another website, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://sportsperspectives.com/2016/12/27/mitsubishi-ufj-trust-banking-corp-boosts-position-in-cigna-corp-ci.html.

A number of equities research analysts have recently commented on CI shares. Zacks Investment Research upgraded Cigna Corp. from a “sell” rating to a “hold” rating in a research report on Tuesday, October 4th. Leerink Swann restated a “buy” rating and set a $155.00 target price on shares of Cigna Corp. in a research report on Monday, September 26th. William Blair restated a “buy” rating on shares of Cigna Corp. in a research report on Wednesday, August 31st. Goldman Sachs Group Inc. restated a “buy” rating and set a $160.00 target price on shares of Cigna Corp. in a research report on Thursday, September 8th. Finally, Jefferies Group restated a “buy” rating and set a $153.00 target price on shares of Cigna Corp. in a research report on Sunday, October 16th. Six equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $156.00.

In other Cigna Corp. news, EVP John M. Murabito sold 58,822 shares of the company’s stock in a transaction dated Monday, November 7th. The shares were sold at an average price of $125.09, for a total transaction of $7,358,043.98. Following the transaction, the executive vice president now directly owns 115,109 shares in the company, valued at $14,398,984.81. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jason D. Sadler sold 4,000 shares of the company’s stock in a transaction dated Monday, October 31st. The stock was sold at an average price of $121.80, for a total transaction of $487,200.00. Following the transaction, the insider now owns 34,019 shares in the company, valued at $4,143,514.20. The disclosure for this sale can be found here. Company insiders own 1.20% of the company’s stock.

Cigna Corp. Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate.

5 Day Chart for NYSE:CI

Receive News & Ratings for Cigna Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply